EPAM vs NBY · P/E 14, rev $2.81B vs $51.9M cap
EPAM Systems Inc (EPAM) versus NovaBay Pharmaceuticals Inc (NBY) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
NovaBay Pharmaceuticals Inc (NBY) is a biotechnology company listed on US.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
NBY does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. NBY currently screens at market cap $51.9M.
Not investment advice. Open the EPAM and NBY stock pages for the full models.
Not investment advice.